Author:
Kuo Shihchen,Ye Wen,Duong Justin,Herman William H.
Funder
Michigan Center for Diabetes Translational Research, Methods and Measurement
National Institute of Diabetes and Digestive and Kidney Diseases
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference22 articles.
1. EMPA-REGOUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015
2. Mitigating cardiovascular risk in type 2 diabetes with antidiabetes drugs: a review of principal cardiovascular outcome results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 trials;Kaul;Diabetes Care,2017
3. Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications;Heerspink;Circulation,2016
4. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes;Gaede;N Engl J Med,2003
5. Michigan Center of Diabetes Translational Research Disease Modeling Group at the University of Michigan. The Michigan Model for Diabetes User Manual for Version 2.0, September 17, 2015. Available at: http://diabetesresearch.med.umich.edu/Core_MCDTR_Methods_DM_MMD.php.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献